| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/07/2019 | 22:55 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 29/07/2019 | 13:31 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 22/07/2019 | 22:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 22/07/2019 | 22:09 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 22/07/2019 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 18/07/2019 | 15:13 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 18/07/2019 | 15:11 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 18/07/2019 | 15:11 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 18/07/2019 | 15:10 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 16/07/2019 | 22:15 | PR Newswire (US) | Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 24/06/2019 | 13:00 | GlobeNewswire Inc. | CureVac Welcomes Two Members to its Supervisory Board | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 17/06/2019 | 12:54 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 11/06/2019 | 22:05 | PR Newswire (US) | Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 07/06/2019 | 22:59 | PR Newswire (US) | Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 29/05/2019 | 22:34 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 09/05/2019 | 14:05 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 08/05/2019 | 22:05 | PR Newswire (US) | Aratana Therapeutics Reports First Quarter 2019 Financial Results | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 07/05/2019 | 14:00 | PR Newswire (US) | Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 26/04/2019 | 20:25 | PR Newswire (US) | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc. | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 26/04/2019 | 12:29 | Business Wire | Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Spec... | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 26/04/2019 | 12:28 | PR Newswire (US) | Aratana Therapeutics to be Acquired by Elanco Animal Health | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 22/04/2019 | 14:30 | PR Newswire (US) | Aratana Therapeutics to Report First Quarter 2019 Financial Results | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 19/04/2019 | 22:19 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 19/04/2019 | 22:12 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 13/03/2019 | 23:57 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 13/03/2019 | 21:30 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 12/03/2019 | 21:05 | PR Newswire (US) | Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 13/02/2019 | 14:30 | PR Newswire (US) | Aratana Therapeutics to Participate at Upcoming Investment Conferences | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 12/02/2019 | 14:30 | PR Newswire (US) | Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results | NASDAQ:PETX | Aratana Therapeutics, Inc. |
| 05/02/2019 | 23:44 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PETX | Aratana Therapeutics, Inc. |